Metastatic Colorectal Cancer Clinical Trials in Montpellier
6 recruitingMontpellier, France
Showing 1–6 of 6 trials
Recruiting
Phase 3
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Amgen450 enrolled284 locationsNCT06252649
Recruiting
Phase 2
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Metastatic Colorectal Cancer
AstraZeneca120 enrolled76 locationsNCT06792695
Recruiting
Phase 2
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
Metastatic Colorectal CancerMetastatic Gastroesophageal AdenocarcinomaDPD Deficiency
UNICANCER73 enrolled21 locationsNCT06245356
Recruiting
Phase 2
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group30 enrolled9 locationsNCT05310643
Recruiting
Phase 2
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon174 enrolled10 locationsNCT06425133
Recruiting
Phase 2Phase 3
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon446 enrolled16 locationsNCT05462613